Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11β-hydroxysteroid dehydrogenase type 1

Endocrinology

Volumn 148, Issue 5, 2007, Pages 2391-2397

  Berthiaume, Magalie ^a   Laplante, Mathieu ^a   Festuccia, William ^a   Gélinas, Yves ^a   Poulin, Sébastien ^a   Lalonde, Josée ^a   Joanisse, Denis R ^b   Thieringer, Rolf ^c   Deshaies, Yves ^a,d  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c MERCK RESEARCH LABORATORIES   (United States)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; ACYL COENZYME A DESATURASE; DGAT1 PROTEIN, RAT; DIACYLGLYCEROL ACYLTRANSFERASE; ENZYME INHIBITOR; FAS ANTIGEN; FAS PROTEIN, MOUSE; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOLIPASE A; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE DIET; CELL SIZE; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; ESTERIFICATION; FATTY ACID OXIDATION; FOOD INTAKE; GENE EXPRESSION; INTRAABDOMINAL FAT; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MALE; MESENTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; RETROPERITONEAL FAT; WEIGHT GAIN; ABDOMINAL FAT; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SUGAR INTAKE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ABDOMINAL FAT; ANIMALS; ANTIGENS, CD95; CARNITINE O-PALMITOYLTRANSFERASE; DIACYLGLYCEROL O-ACYLTRANSFERASE; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPID METABOLISM; LIPOLYSIS; MALE; OBESITY; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOLIPASES A; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STEAROYL-COA DESATURASE;

EID: 34249775822     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1199     Document Type: Article

References (50)

1. Wolf G 2002 Glucocorticoids in adipocytes stimulate visceral obesity. Nutr Rev 60:148-151
2. Boscaro M, Barzon L, Fallo F, Sonino N 2001 Cushing's syndrome. Lancet 357:783-791
3. Masuzaki H, Flier JS 2003 Tissue-specific glucocorticoid reactivating enzyme, 11 β-hydroxysteroid dehydrogenase type 1 (11 β-HSD1): a promising drug target for the treatment of metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 3:255-262
4. Stewart PM 2003 Tissue-specific Cushing's syndrome, 11β-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur J Endocrinol 149:163-168
5. Seckl JR, Walker BR 2001 Minireview: 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology 142:1371-1376
6. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM 2004 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866
7. Bujalska IJ, Kumar S, Hewison M, Stewart PM 1999 Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β- hydroxysteroid dehydrogenase. Endocrinology 140:3188-3196
8. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213
9. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, Walker BR 2000 Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141:560-563
10. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
11. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M 2002 Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 87:2701-2705
12. Rebuffé-Scrive M, Bronnegard M, Nilsson A, Eldh J, Gustafsson JA, Bjorntorp P 1990 Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 71:1215-1219
13. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ 1997 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoidinducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94:14924-14929
14. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR 2001 Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276:41293-41300
15. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR 2004 Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938
16. Li M, Yang S, Bjorntorp P 1993 Metabolism of different adipose tissues in vivo in the rat. Obes Res 1:459-468
17. Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C, Ronquist-Nii Y, Ohman B, Abrahmsen L 2002 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45:1528-1532
18. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Ohman B, Bjorkstrand E, Abrahmsen LB 2003 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144:4755-4762
19. Wang SJ, Birtles S, de Schoolmeester J, Swales J, Moody G, Hislop D, O'Dowd J, Smith DM, Turnbull AV, Arch JR 2006 Inhibition of 11β-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice. Diabetologia 49:1333-1337
20. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS, Noonan H, Nunes CN, Olson SH, Pikounis B, Ren N, Robertson N, Schaeffer JM, Shah K, Springer MS, Strack AM, Strowski M, Wu K, Wu T, Xiao J, Zhang BB, Wright SD, Thieringer R 2005 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202:517-527
21. Shi Y, Burn P 2004 Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov 3:695-710
22. Gu X, Dragovic J, Koo GC, Koprak SL, LeGrand C, Mundt SS, Shah K, Springer MS, Tan EY, Thieringer R, Hermanowski-Vosatka A, Zokian HJ, Balkovec JM, Waddell ST 2005 Discovery of 4-heteroarylbicyclo[2.2.2] octyltriazoles as potent and selective inhibitors of 11β-HSD1: novel therapeutic agents for the treatment of metabolic syndrome. Bioorg Med Chem Lett 15:5266-5269
23. Folch J, Lees M, Sloane Stanley GH 1957 A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
24. Hultin M, Carneheim C, Rosenqvist K, Olivecrona T 1995 Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons. J Lipid Res 36:2174-2184
25. Picard F, Naïmi N, Richard D, Deshaies Y 1999 Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes 48:452-459
26. Colberg SR, Simoneau JA, Thaete FL, Kelley DE 1995 Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95:1846-1853
27. Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR, Holmes MC 2001 Intracellular regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase (11β-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11β-HSD-1-deficient mice. Endocrinology 142:114-120
28. Lehtonen MA, Savolainen MJ, Hassinen IE 1979 Hormonal regulation of hepatic soluble phosphatidate phosphohydrolase. Induction by cortisol in vivo and in isolated perfused rat liver. FEBS Lett 99:162-166
29. Glenny HP, Brindley DN 1978 The effects of cortisol, corticotropin and thyroxine on the synthesis of glycerolipids and on the phosphatidate phosphohydrolase activity in rat liver. Biochem J 176:777-784
30. Klausner H, Heimberg M 1967 Effect of adrenalcortical hormones on release of triglycerides and glucose by liver. Am J Physiol 212:1236-1246
31. Reaven EP, Kolterman OG, Reaven GM 1974 Ultrastructural and physiological evidence for corticosteroid-induced alterations in hepatic production of very low density lipoprotein particles. J Lipid Res 15:74-83
32. Afdhal NH, Mazusaki H, Turner B, Nasser I, Flier J 2002 Transgenic mice with 11β-hydroxysteroid dehydrogenase type 1 overexpression in adipocytes develop fatty liver disease. Hepatology 36:216A
33. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ 2004 Metabolic syndrome without obesity: Hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA 101:7088-7093
34. Bjorntorp P 1990 "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496
35. Appel B, Fried SK 1992 Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue. Am J Physiol 262:E695-E699
36. Ashby P, Robinson DS 1980 Effects of insulin, glucocorticoids and adrenaline on the activity of rat adipose-tissue lipoprotein lipids. Biochem J 188:185-192
37. Zechner R 1997 The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr Opin Lipidol 8:77-88
38. Dobrzyn A, Ntambi JM 2004 The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med 14:77-81
39. Wang Y, Jones Voy B, Urs S, Kim S, Soltani-Bejnood M, Quigley N, Heo YR, Standridge M, Andersen B, Dhar M, Joshi R, Wortman P, Taylor JW, Chun J, Leuze M, Claycombe K, Saxton AM, Moustaid-Moussa N 2004 The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. J Nutr 134:1032-1038
40. Chen HC, Farese RV, Jr 2000 DGAT and triglyceride synthesis: a new target for obesity treatment? Trends Cardiovasc Med 10:188-192
41. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW 2004 Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279:48968-48975
42. Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS 2004 Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 279:47066-47075
43. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R 2004 Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383-1386
44. Ballard FJ, Hanson RW, Leveille GA 1967 Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. J Biol Chem 242:2746-2750
45. Chakravarty K, Cassuto H, Reshef L, Hanson RW 2005 Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol 40:129-154
46. Laplante M, Sell H, MacNaul KL, Richard D, Berger JP, Deshaies Y 2003 PPAR-γ activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52:291-299
47. Williamson JR, Kreisberg RA, Felts PW 1966 Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 56:247-254
48. Sampath H, Ntambi JM 2006 Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-α: independent and interactive roles in the regulation of lipid metabolism. Curr Opin Clin Nutr Metab Care 9:84-88
49. Jenkins BD, Pullen CB, Darimont BD 2001 Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol Metab 12:122-126
50. Meijer OC, Steenbergen PJ, De Kloet ER 2000 Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 141:2192-2199